289 unknown. 289 Phase 3, 79 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 289 | Unknown 289 |
| Phase 2 | 79 | Unknown 79 |
Follow Hematologic Diseases: new trials by email Literature Review of Hematologic Diseases trials Research Report on Hematologic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maternal Under-nutrition and Effect of Amaranth Grain Flat-bread on Anemia Amaranth grain flat bread - Maternal Anemia in Pregnancy, Before Birth, Maternal; Malnutrition, Affecting Fetus | Phase 3 | Unknown | Hawassa University | 306 | 2024-08-10 | 2024-08-02 |
| Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT avatrombopag, Placebo - Thrombocytopenia, Stem Cell Transplant Complications | Phase 2 / Phase 3 | Unknown | Peking University People's Hospital | 142 | 2024-05-13 | 2024-10-01 |
| The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma Nelarabine injection - T-lymphoblastic Leukemia, T-lymphoblastic Lymphoma | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 83 | 2024-05-01 | 2024-05-30 |
| Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult DEC3-VEN - Acute Myeloid Leukemia, Adult | Phase 2 / Phase 3 | Unknown | The Second Affiliated Hospital of Kunming Medical University | 40 | 2024-03-01 | 2024-02-29 |
| A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia Liposomal cytarabine-daunorubicin for injection, 7+3 (cytarabine and daunorubicin) - High-risk (Secondary) Acute Myeloid Leukemia | Phase 3 | Unknown | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 120 | 2024-01-01 | 2023-12-28 |
| A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma BCD-264, Darzalex - Multiple Myeloma | Phase 3 | Unknown | Biocad | 252 | 2023-12-21 | 2024-03-06 |
| Lapelga vs Gastrofil Grastofil®, Lapelga - Multiple Myeloma, Lymphoma | Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 74 | 2023-11-01 | 2023-11-03 |
| EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron), Ferrous fumarate syrup 2.5ml/70mg(45mg elemental iron), Ferrous fumarate syrup 2.5ml/70mg (90mg elemental iron) - Inflammatory Bowel Disease, Iron Deficiency Anemia | Phase 3 | Unknown | Liverpool University Hospitals NHS Foundation Trust | 30 | 2023-10-20 | 2024-03-20 |
| SMILES: Study of Montelukast in Sickle Cell Disease Montelukast, Oral Placebo - Anemia, Sickle Cell, Sleep-Disordered Breathing | Phase 2 / Phase 3 | Unknown | Great Ormond Street Hospital for Children NHS Foundation Trust | 200 | 2023-10-16 | 2023-11-01 |
| CURATE.AI Optimized Modulation for Multiple Myeloma Bortezomib, Cyclophosphamide, Dexamethasone - Multiple Myeloma | Phase 2 / Phase 3 | Unknown | National University Hospital, Singapore | 20 | 2023-09-10 | 2023-09-06 |
| Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer Ascorbate, Nab paclitaxel, Gemcitabine - Metastatic Pancreatic Adenocarcinoma | Phase 3 | Unknown | Fudan University | 100 | 2023-08-20 | 2025-08-07 |
| A Study to Compare Liposomal Iron With Ferrous Ascorbate in the Treatment of Iron Deficiency Anemia in Children Ferric Pyrophosphate Liposomal, ferrous ascorbate - Nutritional Anemia | Phase 3 | Unknown | All India Institute of Medical Sciences | 96 | 2023-08-01 | 2023-07-24 |
| Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A "Emicizumab", "HEMLIBRA®" - Severe Hemophilia A Without Inhibitor, Joint Bleed | Phase 2 / Phase 3 | Unknown | Chulalongkorn University | 15 | 2023-06-22 | 2024-03-05 |
| Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens Erythropoietin - Anemia, Neoplasms | Phase 3 | Unknown | Blau Farmaceutica S.A. | 320 | 2023-05-01 | 2023-01-30 |
| High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia Ferric Derisomaltose Injection, Darbepoetin Alfa Injection - Anemia | Phase 3 | Unknown | Hallym University Medical Center | 312 | 2023-03-01 | 2023-03-15 |
| A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors Shengxuening Tablet, Ferrous succinate - Hematological Malignancy, Cancer-Related Anemia | Phase 3 | Unknown | Zhongnan Hospital | 168 | 2023-02-07 | 2023-08-25 |
| Tacrolimus for Thrombocytopenia in SS Hydroxychloroquine, Tacrolimus - Sjogren Syndrome With Other Organ Involvement | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 54 | 2023-02-01 | 2023-01-10 |
| Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS Prednisolone, Tacrolimus - Sjogren Syndrome With Other Organ Involvement | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 110 | 2023-02-01 | 2023-01-23 |
| Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia Herombopag - Immune Thrombocytopenia | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 117 | 2023-01-23 | 2023-01-17 |
| Safety and Efficacy of Metformin for Treatment of Cytopenia in Children and Adolescents With Fanconi Anemia Metformin - Fanconi Anemia | Phase 3 | Unknown | Ain Shams University | 30 | 2022-10-05 | 2024-07-25 |
Showing 20 of 289. Sign in to see all of them.
Leukemia, Myeloid, Acute (51) · Multiple Myeloma (38) · Leukemia (35) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (29) · Anemia (24) · Leukemia, Lymphocytic, Chronic, B-Cell (19) · Purpura, Thrombocytopenic, Idiopathic (17) · Myelodysplastic Syndromes (16) · Lymphoma (15) · Thrombocytopenia (14) · Lymphoma, Follicular (13) · Hematologic Neoplasms (12) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (11) · Anemia, Sickle Cell (10) · Lymphoma, Large B-Cell, Diffuse (10)
Hemic and Lymphatic Diseases (289) · Neoplasms (165) · Neoplasms by Histologic Type (159) · Immune System Diseases (111) · Immunoproliferative Disorders (86) · Lymphoproliferative Disorders (86) · Leukemia (84) · Pathological Conditions, Signs and Symptoms (84) · Pathologic Processes (77) · Hemorrhagic Disorders (74) · Leukemia, Myeloid (72) · Cardiovascular Diseases (55) · Lymphatic Diseases (54) · Vascular Diseases (53)
Cytarabine (33) · Cyclophosphamide (30) · Dexamethasone (28) · Idarubicin (18) · Decitabine (17) · Etoposide (17) · Daunorubicin (14) · Radiotherapy (13) · Doxorubicin (12) · Busulfan (11) · Methotrexate (11) · Vincristine (11) · Melphalan (10) · Filgrastim (9) · Mercaptopurine (9)
Nanfang Hospital, Southern Medical University (14) · Assistance Publique - Hôpitaux de Paris (13) · European Organisation for Research and Treatment of Cancer - EORTC (10) · The First Affiliated Hospital of Soochow University (10) · Ain Shams University (8) · Shandong University (7) · Medical Research Council (5) · Peking University People's Hospital (5) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (4) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (4) · Peking Union Medical College Hospital (3) · Tehran University of Medical Sciences (3) · All India Institute of Medical Sciences (2) · Assiut University (2) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (2)
China (87) · United Kingdom (28) · France (26) · Germany (23) · Italy (19) · Belgium (15) · United States (14) · Netherlands (13) · Austria (11) · Brazil (10) · Czechia (10) · Israel (10) · Canada (9) · Egypt (9) · Russia (9)
Qifa Liu (4) · Ming Hou, Dr (3) · Qifa Liu, MD (3) · Xiaowen Tang, Ph.D. (3) · Fernando Dimeo, MD (2) · Galina Novichkova (2) · Graham Jackson, MD (2) · Han Yue, Ph.D (2) · Lei Li, M.D. (2) · Mohsen S Elalfy, professor (2) · Ruediger Hehlmann, MD (2) · Samir G Agrawal, MD, PhD (2) · Stephen J. Proctor, MD, FRCP, FRCPath (2) · Theo De Witte, MD, PhD (2) · William A. Wegener, MD, PhD (2)
PMID 34932836, PMID 41114449, PMID 15812540, PMID 20940381, PMID 21195303, PMID 25753432, PMID 29926156, PMID 30523055, PMID 33242441, PMID 35244208, PMID 38780066, PMID 11137554, PMID 11231246, PMID 11675328, PMID 12111109, PMID 12153596, PMID 12510709, PMID 12694250, PMID 12780755, PMID 15010373, PMID 15131807, PMID 15189396, PMID 15711856, PMID 15801953, PMID 15842354, PMID 15952999, PMID 16103468, PMID 16155013, PMID 16427380, PMID 16475046, PMID 17360989, PMID 17366834, PMID 17859247, PMID 18083847, PMID 18094721, PMID 18166796, PMID 18182574, PMID 18239868, PMID 18276714, PMID 18358930, PMID 19005182, PMID 19095121, PMID 19166855, PMID 19242495, PMID 19387663, PMID 19826132, PMID 19880501, PMID 19952380, PMID 20006130, PMID 20011381
2005 (2), 2009 (1), 2014 (1), 2015 (1), 2016 (1), 2019 (1)